[1] WORLD HEALTH ORGANIZATION. 10 facts on obesity[EB/OL].[2019-09-11].https://www.who.int/features/factfiles/obesity/zh/. [2] FLOYD Z E, GAWRONSKA-KOZAK B, TAM C S, et al. Mechanisms of metabolism, aging and obesity[J]. Biochimie, 2016, 124:1-2. [3] LEE S J, SHIN S W. Mechanisms, pathophysiology, and management of obesity[J]. N Engl J Med, 2017, 376(15):1490-1492. [4] KOPELMAN P G. Obesity as a medical problem[J]. Nature, 2000, 404(6778):635-643. [5] CHANG E, KIM C Y. Natural products and obesity:a focus on the regulation of mitotic clonal expansion during adipogenesis[J]. Molecules, 2019, 24(6):E1157. [6] XU L Y, ZHAO W J, WANG D M, et al. Chinese medicine in the battle against obesity and metabolic diseases[J]. Front Physiol, 2018, 9:850. [7] 杨大伟, 王民登, 吴标良, 等. 胰岛素抵抗的研究进展[J]. 右江医学, 2019, 47(6):472-475. [8] YEE H Y, 杨晶晶, 万毅刚, 等. 胰岛素抵抗的分子机制及中药的干预作用[J]. 中国中药杂志, 2019, 44(7):1289-1294. [9] SCOTT R E, FLORINE D L, WILLE J J J R, et al. Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle:GD[J]. Proc Natl Acad Sci U S A, 1982, 79(3):845-849. [10] PAIRAULT J, GREEN H. A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker[J]. Proc Natl Acad Sci U S A, 1979, 76(10):5138-5142. [11] MACDOUGALD O A, MANDRUP S. Adipogenesis:forces that tip the scales[J]. Trends Endocrinol Metab, 2002, 13(1):5-11. [12] WU J H, SRINIVASAN S V, NEUMANN J C, et al. The KLF2 transcription factor does not affect the formation of preadipocytes but inhibits their differentiation into adipocytes[J]. Biochemistry, 2005, 44(33):11098-11105. [13] TONTONOZ P, HU E, SPIEGELMAN B M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor[J]. Cell, 1994, 79(7):1147-1156. [14] TANG Q Q, ZHANG J W, DANIEL LANE M.Sequential gene promoter interactions by C/EBPβ, C/EBPα, and PPARγ during adipogenesis[J]. Biochem Biophys Res Commun, 2004, 318(1):213-218. [15] LONDOS C, BRASAEMLE D L, SCHULTZ C J, et al. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells[J]. Semin Cell Dev Biol, 1999, 10(1):51-58. [16] KOERNER A, KRATZSCH J, KIESS W. Adipocytokines:leptin:the classical, resistin:the controversical, adiponectin:the promising, and more to come[J]. Best Pract Res Clin Endocrinol Metab, 2005, 19(4):525-546. [17] HUANG B, YUAN H D, KIM D Y, et al. Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-γ (PPARγ) and AMP-activated protein kinase (AMPK) pathways[J]. J Agric Food Chem, 2011, 59(8):3666-3673. [18] 李慧玲, 吴骁, 王丹, 等. 木犀草苷对3T3-L1前脂肪细胞分化的抑制作用[J]. 中国医药导报, 2017, 14(2):16-19. [19] JANG B C. Artesunate inhibits adipogeneis in 3T3-L1 preadipocytes by reducing the expression and/or phosphorylation levels of C/EBP-α, PPAR-γ, FAS, perilipin A, and STAT-3[J]. Biochem Biophys Res Commun, 2016, 474(1):220-225. [20] PARK Y K, OBIANG-OBOUNOU B W, LEE J, et al. Anti-adipogenic effects on 3T3-L1 cells and zebrafish by tanshinone ⅡA[J]. Int J Mol Sci, 2017, 18(10):E2065. [21] 赵丹, 王艳艳, 梁雄杰, 等. 淫羊藿苷对3T3-L1前脂肪细胞增殖及分化的影响[J]. 现代中西医结合杂志, 2017, 26(22):2398-2400, 2404. [22] LI H, YUAN Y F, ZHANG Y L, et al. Icariin inhibits AMPK-dependent autophagy and adipogenesis in adipocytes in vitro and in a model of Graves' orbitopathy in vivo[J]. Front Physiol, 2017, 8:45. [23] CHE Y Y, WANG Q H, XIAO R Y, et al. Kudinoside-D, a triterpenoid saponin derived from Ilex Kudingcha suppresses adipogenesis through modulation of the AMPK pathway in 3T3-L1 adipocytes[J]. Fitoterapia, 2018, 125:208-216. [24] JANG M K, YUN Y R, KIM J H, et al. Gomisin N inhibits adipogenesis and prevents high-fat diet-induced obesity[J]. Sci Rep, 2017, 7:40345. [25] LIU X N, WANG S F, WU Z S, et al. Deoxyschizandrin loaded liposomes on the suppression lipid accumulation in 3T3-L1 adipocytes[J]. Molecules, 2018, 23(9):E2158. [26] 栗茜, 彭莎, 候宁, 等. 穿心莲内酯通过下调PPARγ-C/EBPα抑制脂滴形成[J]. 天津中医药, 2018, 35(6):454-459. [27] ZHANG T, ZHAO Q, XIAO X R, et al. Modulation of lipid metabolism by celastrol[J]. J Proteome Res, 2019, 18(3):1133-1144. [28] LIU H M, LIU M H, JIN Z B, et al. Ginsenoside Rg2 inhibits adipogenesis in 3T3-L1 preadipocytes and suppresses obesity in high-fat-diet-induced obese mice through the AMPK pathway[J]. Food Funct, 2019, 10(6):3603-3614. [29] HAO M J, LI Y, LIU L X, et al. The design and synthesis of a novel compound of berberine and baicalein that inhibits the efficacy of lipid accumulation in 3T3-L1 adipocytes[J]. Bioorg Med Chem, 2017, 25(20):5506-5512. [30] LIANG Y C, HU J C, LI P Y, et al. Torenia concolor Lindley var. formosana Yamazaki extracts improve inflammatory response and lipid accumulation via PPARs activation[J]. Biomedicine (Taipei), 2017, 7(3):18. [31] 李吉萍, 张文友, 孙婷婷, 等. 板蓝根水提物对3T3-L1前脂肪细胞增殖和分化的影响[J]. 中国药理学通报, 2017, 33(8):1159-1164. [32] 刘新迎, 王培训. 黄芪提取物对3T3-L1细胞的影响及其部分作用机制[J]. 现代中医药, 2018, 38(1):86-88, 102. [33] 李慧玲, 刘天竹, 王丹, 等. 豆茶决明冲剂含药血清对3T3-L1前脂肪细胞分化的抑制作用[J]. 中药药理与临床, 2018, 34(1):89-92. [34] ZHANG X H, WANG Z Q, KANG B G, et al. Antiobesity effect of Astilbe chinensis franch. Et savet. Extract through regulation of adipogenesis and AMP-activated protein kinase pathways in 3T3-L1 adipocyte and high-fat diet-induced C57BL/6N obese mice[J]. Evid Based Complement Alternat Med, 2018, 2018:1347612. [35] MA L, HUANG L, PEI H Y, et al. Pharmacological effects of the water fraction of key components in the traditional Chinese prescription Mai Tong Fang on 3T3-L1 adipocytes and ob/ob diabetic mice[J]. Molecules, 2014, 19(9):14687-14698. [36] YANG Z Z, WANG L L, ZHANG F, et al. Evaluating the antidiabetic effects of Chinese herbal medicine:Xiao-Ke-An in 3T3-L1 cells and KKAy mice using both conventional and holistic omics approaches[J]. BMC Complement Altern Med, 2015, 15:272. [37] LEE H, SHIM E H, LEE M S, et al. Traditional medicine, Sobokchukeo-Tang, modulates the inflammatory response in adipocytes and macrophages[J]. Mol Med Rep, 2017, 15(1):117-124. [38] PAN Y Y, ZHAO D D, YU N, et al. Curcumin improves glycolipid metabolism through regulating peroxisome proliferator activated receptor γ signalling pathway in high-fat diet-induced obese mice and 3T3-L1 adipocytes[J]. R Soc Open Sci, 2017, 4(11):170917. [39] LI X W, HUANG M X, LO K, et al. Anti-diabetic effect of a shihunine-rich extract of Dendrobiumloddigesii on 3T3-L1 cells and db/db mice by up-regulating AMPK-GLUT4-PPARα[J]. Molecules, 2019, 24(14):E2673. [40] LIU Z H, XU L T, XU X Q, et al. Effects and mechanisms of iridoid glycosides from Patrinia scabiosaefolia on improving insulin resistance in 3T3-L1 adipocytes[J]. Food Chem Toxicol, 2019, 134:110806. [41] ANUSREE S S, SINDHU G, PREETHA RANI M R, et al. Insulin resistance in 3T3-L1 adipocytes by TNF-α is improved by punicic acid through upregulation of insulin signalling pathway and endocrine function, and downregulation of proinflammatory cytokines[J]. Biochimie, 2018, 146:79-86. [42] XU X Q, SAADELDEEN F S A, XU L T, et al. The mechanism of phillyrin from the leaves of Forsythia suspensa for improving insulin resistance[J]. Biomed Res Int, 2019, 2019:3176483. [43] SHEN S N, LIAO Q W, ZHANG T, et al. Myricanol modulates skeletal muscle-adipose tissue crosstalk to alleviate high-fat diet-induced obesity and insulin resistance[J]. Br J Pharmacol, 2019, 176(20):3983-4001. [44] 蔡红蝶, 宿树兰, 郭盛, 等. 黄蜀葵花中黄酮类成分对前脂肪细胞增殖、分化及胰岛素抵抗的影响[J]. 中国中药杂志, 2016, 41(24):4635-4641. [45] ZHANG R X, QIN X Z, ZHANG T, et al. Astragalus polysaccharide improves insulin sensitivity via AMPK activation in 3T3-L1 adipocytes[J]. Molecules, 2018, 23(10):E2711. [46] LI J P, YUAN Y, ZHANG W Y, et al. Effect of Radix isatidis polysaccharide on alleviating insulin resistance in type 2 diabetes mellitus cells and rats[J]. J Pharm Pharmacol, 2019, 71(2):220-229. [47] 武晓丹, 刘欢, 周晶, 等. 三黄消渴汤对胰岛素抵抗3T3-L1脂肪细胞的影响[J]. 时珍国医国药, 2015, 26(3):560-562. [48] 罗新新, 朱水兰, 李冰涛, 等. 葛根芩连汤激活PPARγ上调脂联素和GLUT4表达改善脂肪胰岛素抵抗[J]. 中国中药杂志, 2017, 42(23):4641-4648. [49] YUAN L, TANG P, LI H J, et al. Serum from Jiao-Tai-Wan treated rats increases glucose consumption by 3T3-L1 adipocytes through AMPK pathway signaling[J]. Biosci Rep, 2019, 39(4):BSR20181286. [50] SUOLANG P C, LIU B Q, CHEN J, et al. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways[J]. J Ethnopharmacol, 2019, 236:316-325. [51] CHAWLA A, LAZAR M A. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival[J]. Proc Natl Acad Sci U S A, 1994, 91(5):1786-1790. [52] ROSEN E D, HSU C H, WANG X Z, et al. C/EBPalpha induces adipogenesis through PPARgamma:a unified pathway[J]. Genes Dev, 2002, 16(1):22-26. [53] ROSEN E D, SARRAF P, TROY A E, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro[J]. Mol Cell, 1999, 4(4):611-617. [54] WRIGHT H M, CLISH C B, MIKAMI T, et al. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation[J]. J Biol Chem, 2000, 275(3):1873-1877. [55] CAMP H S, CHAUDHRY A, LEFF T. A novel potent antagonist of peroxisome proliferator-activated receptor γ blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes[J]. Endocrinology, 2001, 142(7):3207-3213. |